|
90
|
309
|
3ky2A |
Crystal structure of fibroblast growth factor receptor 1 kinase domain |
|
101
|
356
|
3kvxA |
Jnk3 bound to aminopyrimidine inhibitor, sr-3562 |
|
103
|
304
|
3lcsA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
|
103
|
308
|
3l9pA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
|
109
|
326
|
3kxmA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor k74 |
|
82
|
264
|
3kxzA |
The complex crystal structure of lck with a probe molecule w259 |
|
92
|
271
|
3lckA |
The kinase domain of human lymphocyte kinase (lck), activated form (auto-phosphorylated on tyr394) |
|
107
|
340
|
3l9lA |
Crystal structure of pka with compound 36 |
|
102
|
308
|
3lctA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
|
93
|
297
|
3lcdA |
Inhibitor bound to a dfg-in structure of the kinase domain of csf-1r |
|
109
|
327
|
3kxgA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64) |
|
181
|
642
|
3krxA |
Human grk2 in complex with gbetgamma subunits and balanol (co-crystal) |
|
94
|
360
|
3l1sA |
3-aryl-4-(arylhydrazono)-1h-pyrazol-5-ones: highly ligand efficient and potent inhibitors of gsk3 |
|
82
|
307
|
3l8vA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a biarylamine based inhibitor |
|
87
|
274
|
3kulA |
Kinase domain of human ephrin type-a receptor 8 (epha8) |
|
85
|
305
|
3kxxA |
Structure of the mutant fibroblast growth factor receptor 1 |
|
125
|
408
|
3kvwA |
Crystal structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (dyrk2) in complex with an indirubin ligand |
|
194
|
642
|
3krwA |
Human grk2 in complex with gbetgamma subunits and balanol (soak) |
|
109
|
340
|
3l9mA |
Crystal structure of pkab3 (pka triple mutant v123a, l173m, q181k) with compound 18 |
|
89
|
308
|
3l8pA |
Crystal structure of cytoplasmic kinase domain of tie2 complexed with inhibitor cep11207 |
|
108
|
327
|
3kxhA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl-acetic acid (k66) |
|
160
|
464
|
3ku2A |
Crystal structure of inactivated form of cdpk1 from toxoplasma gondii, tgme49.101440 |
|
98
|
349
|
3l8xA |
P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor |
|
87
|
318
|
3krjA |
Cfms tyrosine kinase in complex with 4-cyano-1h-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide |
|
69
|
297
|
3kexA |
Crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (her3) |
|
92
|
318
|
3ka0A |
Mk2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide |
|
76
|
264
|
3kl8A |
Camkiintide inhibitor complex |
|
112
|
348
|
3kq7A |
Structure of human p38alpha with n-[4-methyl-3-(6-{[2-(1-methylpyrrolidin-2-yl)ethyl]amino}pyridine-3-amido)phenyl]-2-(morpholin-4-yl)pyridine-4-carboxamide |
|
104
|
348
|
3kf7A |
Crystal structure of human p38alpha complexed with a triazolopyrimidine compound |
|
86
|
315
|
3kn5A |
Crystal structure of the c-terminal kinase domain of msk1 in complex with amp-pnp |
|
83
|
282
|
3kk9A |
Camkii substrate complex b |
|
78
|
268
|
3kmwA |
Crystal structure of the ilk/alpha-parvin core complex (mgatp) |
|
105
|
338
|
3kkvA |
Structure of pka with a protein kinase b-selective inhibitor. |
|
91
|
330
|
3kcfA |
Crystal structure of tgfbri complexed with a pyrazolone inhibitor |
|
66
|
267
|
3kmuA |
Crystal structure of the ilk/alpha-parvin core complex (apo) |
|
90
|
284
|
3kk8A |
Camkii substrate complex a |
|
84
|
315
|
3krlA |
Cfms tyrosine kinase in complex with 5-cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide |
|
93
|
315
|
3kn6A |
Crystal structure of the c-terminal kinase domain of msk1 |
|
90
|
284
|
3kfaA |
Structural analysis of dfg-in and dfg-out dual src-abl inhibitors sharing a common vinyl purine template |
|
85
|
305
|
3kc3A |
Mk2 complexed to inhibitor n4-(7-(benzofuran-2-yl)-1h-indazol-5-yl)pyrimidine-2,4-diamine |
|
83
|
271
|
3kmmA |
Structure of human lck kinase with a small molecule inhibitor |
|
92
|
289
|
3kckA |
A novel chemotype of kinase inhibitors |
|
99
|
293
|
3krrA |
Crystal structure of jak2 complexed with a potent quinoxaline atp site inhibitor |
|
88
|
286
|
3kf4A |
Structural analysis of dfg-in and dfg-out dual src-abl inhibitors sharing a common vinyl purine template |
|
81
|
290
|
3kb7A |
Crystal structure of polo-like kinase 1 in complex with a pyrazoloquinazoline inhibitor |
|
83
|
273
|
3kulB |
Kinase domain of human ephrin type-a receptor 8 (epha8) |
|
90
|
297
|
3kgaA |
Crystal structure of mapkap kinase 2 (mk2) complexed with a potent 3-aminopyrazole atp site inhibitor |
|
79
|
275
|
3jy0A |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
81
|
267
|
3k54A |
Structures of human bruton's tyrosine kinase in active and inactive conformations suggests a mechanism of activation for tec family kinases. |
|
89
|
289
|
3jy9A |
Janus kinase 2 inhibitors |
